JPS5612353A - Compound useful as collagenase inhibitor - Google Patents

Compound useful as collagenase inhibitor

Info

Publication number
JPS5612353A
JPS5612353A JP8721180A JP8721180A JPS5612353A JP S5612353 A JPS5612353 A JP S5612353A JP 8721180 A JP8721180 A JP 8721180A JP 8721180 A JP8721180 A JP 8721180A JP S5612353 A JPS5612353 A JP S5612353A
Authority
JP
Japan
Prior art keywords
compound useful
collagenase inhibitor
collagenase
inhibitor
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8721180A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6338024B2 (enExample
Inventor
Edowaado Sandeiin Jiyosefu
Dejineka Tamara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of JPS5612353A publication Critical patent/JPS5612353A/ja
Publication of JPS6338024B2 publication Critical patent/JPS6338024B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/08—Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/58—Preparation of carboxylic acid halides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP8721180A 1979-06-25 1980-06-25 Compound useful as collagenase inhibitor Granted JPS5612353A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/051,915 US4235885A (en) 1979-06-25 1979-06-25 Inhibitors of mammalian collagenase

Publications (2)

Publication Number Publication Date
JPS5612353A true JPS5612353A (en) 1981-02-06
JPS6338024B2 JPS6338024B2 (enExample) 1988-07-28

Family

ID=21974174

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8721180A Granted JPS5612353A (en) 1979-06-25 1980-06-25 Compound useful as collagenase inhibitor

Country Status (8)

Country Link
US (1) US4235885A (enExample)
EP (1) EP0021766B1 (enExample)
JP (1) JPS5612353A (enExample)
AU (1) AU539714B2 (enExample)
CA (1) CA1180324A (enExample)
DE (1) DE3061889D1 (enExample)
IE (1) IE49914B1 (enExample)
ZA (1) ZA803198B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991008222A1 (en) * 1989-11-24 1991-06-13 Banyu Pharmaceutical Co., Ltd. Physiologically active substance be-16627
JP2008511679A (ja) * 2004-09-02 2008-04-17 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド ヒストンデアセチラーゼ阻害剤としてのメルカプトアミド
JP2016210717A (ja) * 2015-05-07 2016-12-15 日油株式会社 Ｎ−アシルアミノ酸の製造方法

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4611002A (en) * 1977-07-14 1986-09-09 E. R. Squibb And Sons, Inc. Carboxymethyl esters of mercaptopropanoic acids as enkephalinase inhibitors
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
US4692458A (en) * 1980-03-05 1987-09-08 University Of Miami Anti-hypertensive agents
CA1182818A (en) * 1980-05-30 1985-02-19 Joseph E. Sundeen N-substituted mercaptoacyl propionamides
US4382081A (en) * 1981-06-12 1983-05-03 E. R. Squibb & Sons, Inc. Inhibitors of mammalian collagenase
US4424354A (en) 1981-06-12 1984-01-03 E. R. Squibb & Sons, Inc. Inhibitors of mammalian collagenase
US4371466A (en) * 1981-10-07 1983-02-01 American Home Products Corporation Mammalian collagenase inhibitors
US4371465A (en) * 1981-10-07 1983-02-01 American Home Products Corporation Mammalian collagenase inhibitors
US4374765A (en) * 1981-10-07 1983-02-22 American Home Products Corporation Mammalian collagenase inhibitors
US4474795A (en) * 1981-10-09 1984-10-02 E. R. Squibb & Sons, Inc. Enkephalinase inhibitors
US4401677A (en) * 1981-10-09 1983-08-30 E. R. Squibb & Sons, Inc. Enkephalinase inhibitors
US4474799A (en) * 1981-10-09 1984-10-02 E. R. Squibb & Sons, Inc. Enkephalinase inhibitors
DE3467754D1 (de) * 1983-10-03 1988-01-07 Squibb & Sons Inc Enkephalinase inhibitors
US4774256A (en) * 1983-10-03 1988-09-27 E. R. Squibb & Sons, Inc. Use of enkephalinase inhibitors as analgesic agents
US4722810A (en) * 1984-08-16 1988-02-02 E. R. Squibb & Sons, Inc. Enkephalinase inhibitors
US4798904A (en) * 1983-10-03 1989-01-17 E. R. Squibb & Sons, Inc. Certain [(lower alkanoyl-thio)methyl-1-oxo-3-phenyl propyl amino]benzene lower alkanoic acid or ester derivatives which inhibit enkephalinase
FR2556721B1 (fr) * 1983-12-14 1986-05-16 Roussel Uclaf Nouveaux derives de o-mercaptopropanamide d'o amino-acides, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
US4595700A (en) * 1984-12-21 1986-06-17 G. D. Searle & Co. Thiol based collagenase inhibitors
CA1337400C (en) * 1987-06-08 1995-10-24 Norma G. Delaney Inhibitors of neutral endopeptidase
US4855315A (en) * 1988-09-02 1989-08-08 E. R. Squibb & Sons, Inc. Use of zofenopril for the treatment of rheumatoid arthritis
WO1992022523A2 (en) * 1991-06-14 1992-12-23 Research Corporation Technologies, Inc. Peptide derivatives of collagenase inhibitor
US6140099A (en) * 1994-05-20 2000-10-31 The Trustees Of The University Of Pennsylvania Method of delaying fetal membrane rupture by inhibiting matrix metalloproteinase-9 activity
US5641636A (en) * 1994-05-20 1997-06-24 University Of Pennsylvania Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity
JP3787605B2 (ja) 1994-10-05 2006-06-21 ダーウィン・ディスカバリー・リミテッド ペプチジル化合物および金属プロテアーゼのインヒビターとしてのその治療的使用
US5840698A (en) * 1994-10-27 1998-11-24 Affymax Technologies N.V. Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use
US5831004A (en) * 1994-10-27 1998-11-03 Affymax Technologies N.V. Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
US6294694B1 (en) 1999-06-04 2001-09-25 Wisconsin Alumni Research Foundation Matrix metalloproteinase inhibitors and method of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) * 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4053651A (en) * 1976-05-10 1977-10-11 E. R. Squibb & Sons, Inc. Compounds and method for alleviating angiotensin related hypertension
US4179434A (en) * 1977-01-17 1979-12-18 E. R. Squibb & Sons, Inc. Amino acid derivatives
CA1125783A (en) * 1978-03-27 1982-06-15 Michael E. Condon Thioalkanoylalkanoic acid compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991008222A1 (en) * 1989-11-24 1991-06-13 Banyu Pharmaceutical Co., Ltd. Physiologically active substance be-16627
JP2008511679A (ja) * 2004-09-02 2008-04-17 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド ヒストンデアセチラーゼ阻害剤としてのメルカプトアミド
JP2016210717A (ja) * 2015-05-07 2016-12-15 日油株式会社 Ｎ−アシルアミノ酸の製造方法

Also Published As

Publication number Publication date
CA1180324A (en) 1985-01-02
IE49914B1 (en) 1986-01-08
EP0021766B1 (en) 1983-02-09
AU539714B2 (en) 1984-10-11
EP0021766A3 (en) 1981-05-13
DE3061889D1 (en) 1983-03-17
US4235885A (en) 1980-11-25
IE801251L (en) 1980-12-25
ZA803198B (en) 1981-05-27
AU5885080A (en) 1981-02-05
JPS6338024B2 (enExample) 1988-07-28
EP0021766A2 (en) 1981-01-07

Similar Documents

Publication Publication Date Title
JPS5612353A (en) Compound useful as collagenase inhibitor
JPS54119486A (en) 66substituted thiaaaza compound
JPS5665892A (en) 6 betaahydroxyalkylpenicillaic acid derivative as betaalactamase inhibitor
JPS5594363A (en) Phenoxyphenylpiperidine compound
GB2025999B (en) Bistrialkoxysiloxy - silane compound
JPS5610183A (en) 199hydroxyypgi compound
JPS5686134A (en) Eicosapentanoate compound
JPS54163582A (en) 22phenoxyy55 trifluoromethypiridine compound
JPS55124743A (en) 99aminoalkylfluorene compound
JPS55143971A (en) 144methoxymorphinann66one compound
JPS56113779A (en) Compound
JPS5657788A (en) Acetoxymethylpenam compound as betaalactamase inhibitor
JPS54160397A (en) Antiirhinouiruse compound
JPS55136288A (en) Betaalactam contained compound
JPS54128538A (en) 44nitroo22trichlormethyllphenyldisulfide compound
JPS54125625A (en) 33hydroxybenzyl compound
GB2048857B (en) -lactamase inhibitors
JPS567790A (en) Novel penicillinn1*11dioxide compound
JPS5667369A (en) Phthaloperinone compound
JPS5559193A (en) Bblactam compound
JPS5594364A (en) Phenylthiophenylpiperidine compound
ZA791752B (en) 4-aza-17 beta -substituted-5 alpha -androstan-3-ones useful as 5 alpha -reductase inhibitors
JPS55113769A (en) 44substitutedd22iminoimidazolidine compound
JPS5620574A (en) Novel deterioration preventing compound
JPS55147293A (en) Novel thiazolinoazetidinone compound